What is the approach to managing sleep disordered breathing in children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Approach to Sleep Disordered Breathing in Children

For otherwise healthy children with sleep disordered breathing and adenotonsillar hypertrophy, adenotonsillectomy is the first-line definitive treatment, but clinicians must recognize that success rates are highly variable—ranging from 80% in younger, normal-weight children to less than 50% in obese children—and families must be counseled that additional interventions may be necessary. 1

Initial Diagnostic Evaluation

When to Obtain Polysomnography (PSG)

Mandatory PSG before surgery: 1

  • Children with obesity
  • Down syndrome
  • Craniofacial abnormalities
  • Neuromuscular disorders
  • Sickle cell disease
  • Mucopolysaccharidoses

Consider PSG when: 1

  • Need for surgery is uncertain
  • Discordance between tonsillar size on examination and reported severity of symptoms
  • Parents desire confirmation of diagnosis

PSG may be omitted: 1

  • Otherwise healthy child with strong history of struggling to breathe
  • Daytime symptoms present
  • Enlarged tonsils on examination
  • No comorbidities

Clinical Assessment Focus

Look specifically for: 1

  • Tonsillar size and degree of obstruction
  • Body mass index and obesity status
  • Ethnicity (African American children have lower cure rates)
  • Age (younger children have better outcomes)
  • Severity of OSA symptoms
  • Presence of chronic rhinitis or deviated nasal septum 2

Primary Treatment: Adenotonsillectomy

Expected Success Rates

Younger, normal-weight, non-African American children: 80% resolution 1, 3

Obese children: Less than 50% complete resolution 1, 3

Overall success rate (AHI <2 events/hour): 79% based on the CHAT trial 1

Complete cure rates: Only 27-40% in some populations 3

Predictors of Treatment Failure

Children at higher risk for persistent OSA after surgery: 3, 2

  • Age greater than 7 years
  • Obesity (50% prevalence of persistent OSA)
  • Baseline severe OSA (AHI >10/hour)
  • African American ethnicity
  • Chronic rhinitis
  • Deviated nasal septum
  • Small tonsil size despite symptoms
  • Underlying genetic or metabolic disorders

Perioperative Management

Communicate PSG results to anesthesiologist before surgery 1

Admit for overnight monitoring if: 1

  • Age younger than 3 years
  • Severe OSA on PSG (AHI ≥10 events/hour)
  • Oxygen saturation nadir <80%

Management of Persistent or Recurrent OSA

Approximately 30-73% of children will have residual OSA after adenotonsillectomy, making post-operative assessment critical. 3

Post-Operative Evaluation

Obtain follow-up PSG in: 1, 3

  • Children with persistent snoring or symptoms
  • High-risk patients (obese, older age, severe pre-operative OSA, comorbidities)
  • Those with severely abnormal preoperative PSG

Second-Line Interventions

For persistent OSA, evaluate and treat: 4, 3

  1. Lingual tonsillar hypertrophy - Consider lingual tonsillectomy if identified 4

  2. Weight management - Mandatory for overweight/obese children 1, 4, 3

  3. CPAP therapy - For children who don't qualify for site-specific upper airway treatment 1, 4, 3

  4. Medical management: 5

    • Nasal steroids for mild to moderate OSA
    • Leukotriene receptor antagonists for mild to moderate OSA
    • Treatment of chronic rhinitis
  5. Orthodontic intervention - Rapid maxillary expansion if specific craniofacial features present 4, 5

  6. Advanced surgical procedures - For select cases 1, 3

Special Populations

Obese children: 1

  • CPAP may be reasonable alternative to surgery as first-line treatment
  • Tonsillectomy often leads to weight gain, potentially worsening OSA
  • Multimodal approach typically required

Children with Down syndrome or mucopolysaccharidoses: 6

  • Adenotonsillectomy and CPAP appear equally effective based on limited evidence

Critical Counseling Points

Families must understand before surgery: 1

  1. Enlarged tonsils are the most common but not sole cause of OSA—muscle tone plays a role 1

  2. Obesity is a major independent contributor 1

  3. Surgery success varies by age, weight, ethnicity, OSA severity, and medical conditions 1

  4. Additional interventions may be necessary including weight loss, medications, CPAP, or further surgery 1, 3

  5. OSA may persist or recur after surgery 1

Document this counseling in the medical record 1

Common Pitfalls to Avoid

  • Assuming tonsillectomy will completely resolve OSA in all children 3
  • Failing to obtain PSG in high-risk populations before surgery 1
  • Not considering post-operative PSG in children with persistent symptoms or risk factors 1, 3
  • Overlooking weight gain after tonsillectomy as a contributor to residual OSA 1
  • Ignoring non-tonsillar factors (muscle tone, obesity, craniofacial anatomy) 1
  • Not addressing chronic rhinitis or nasal obstruction as contributing factors 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Predictors of failure of DISE-directed adenotonsillectomy in children with sleep disordered breathing.

Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale, 2017

Guideline

Residual Obstructive Sleep Apnea After Tonsillectomy in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Pediatric Recurrent Tonsillitis with OSA and Adenoid Enlargement

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment Options for Pediatric Obstructive Sleep Apnea.

Current problems in pediatric and adolescent health care, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.